MADISON, Wis. -- BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies in pain biology, sensory transduction, and ion channel pharmacology. BrainXell sensory neurons demonstrate robust expression of hallmark sensory neuron genes and proteins, including voltage-gated sodium channels [...]

BURLINGTON, Mass. -- Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash [...]

New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold increase in productivity Host provides robust, long-term genetic and phenotypic stability, supporting reliable performance and providing greater confidence through scale-up and regulatory milestones Göttingen, Germany -- Sartorius is addressing the increasing demand for faster and more efficient [...]

NATICK, Mass. -- Pillar Biosciences today announced the launch of the oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate key acute myeloid leukemia (AML) genomic results more efficiently. AML is an aggressive hematologic malignancy where molecular characterization can be time-sensitive in research settings for operational workflow and investigational assessment. The [...]

Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services BELTSVILLE, Md. -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs). Operating from its Beltsville, Maryland facility, REPROCELL now offers a comprehensive, end-to-end workflow for [...]

PORT WASHINGTON, N.Y. – Pall Corporation, a Danaher company and a global leader in filtration, separation and purification, announced the appointment of Dr. Roland Folz as President, Pall Corporation, effective March 3, 2026. As President, Dr. Folz will lead Pall’s global business and set the company’s strategic direction, working closely with the leadership team to [...]

Zurich – BC Platforms, a global leader in healthcare data, technology, and analytics today announced enhancements to BC Mosaic, its AI-powered trusted research environment (TRE), now available on AWS Marketplace. Featuring an all-new, intuitive user interface, BC Mosaic enables secure, compliant analysis of complex clinical, real-world, and multi-omics data within a single trusted research environment. Designed to make trusted [...]

LEHI, Utah & COLUMBIA, Md. -- Axcend and MassTech, Inc. announced that Axcend will offer the MassTech MTE30 as part of a combined liquid chromatography–mass spectrometry (LC–MS) solution designed to support trace-level detection in laboratory, manufacturing, and field-based environments. By pairing the Axcend Focus LC® with the MassTech MTE30, the companies are enabling organizations to perform [...]

Berlin – The MOLNÁR-INSTITUTE for Applied Chromatography has produced a new version of its Automation Module that is now compatible with Agilent’s OpenLab CDS chromatography data system software. DryLab® Automation module was previously available only for the Waters Empower CDS platform. Empower CDS users were able to benefit from the extended DryLab® functionality that included [...]

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa. -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic (PBPK) modeling predictions accepted by the U.S. FDA in lieu of clinical studies to support the new drug application [...]